mentor mentorship pharmaceutical industry services vendor mms holdings cro

According to Mentoring.org, young adults who are mentored are 130 percent more likely to hold leadership positions in the future. Strong mentors assist is building strong junior-level colleagues – especially in the pharmaceutical and biotech industries.

As with all relationships, the mentor-mentee relationship must be approached with care, encouragement, and openness. Based on internal success at the CRO level, MMS experts have compiled a list of the 20 things that good mentors should do, including:

  • Set expectations for the relationship from day 1
  • Understand that no two mentees are alike, and each should be approached differently
  • Hold regular touch point discussions with the mentee
  • Set your phone down for the meeting and give full attention
  • Genuinely get to know them – personally and professionally
  • Ask about their short- and long-term career goals
  • Hear them out, unbiased – sometimes younger mentees may seem “out there” with their logic; yet take the time to listen
  • Take the initiative to follow up – do not let it be one-sided
  • Ask them open-ended questions to ensure that relevant advice sinks in
  • Provide constructive feedback
  • Share stories on mistakes as much as successes
  • Remember what it meant to be “just starting out”
  • Encourage them to ask all questions, even the “dumb” ones
  • Give them homework – something to dive deeper on
  • Be responsive to follow ups from the mentee
  • Introduce them to someone else – our industry is only so big, after all
  • Celebrate milestones with them
  • Be honest with them
  • Give them more than expected
  • Be patient
  • Lead by example

Suggested For You

perspectives

July 30th, 2024

The Critical Role of Quality Control (QC) – Medical Writing and Beyond

perspectives

July 23rd, 2024

PSI 2024 Ignited Conversations on External Data Sources, Requirements for Estimands, and Bayesian Methodology for Statisticians in Pharma

perspectives

July 16th, 2024

Key Steps to Successful CMC Authoring of IND and IMPD Submissions

perspectives

July 9th, 2024

Managing RTOR Submissions: How to Run a Successful Race from the Top Line Starting Line

perspectives

July 2nd, 2024

Part 1: RWD Noninterventional Study Design and FDA Engagement Opportunity for Early Stage Oncology

perspectives

June 21st, 2024

Peer-Reviewed Journal Articles: The Crucial Role of Publication in the Pharmaceutical Industry

perspectives

June 14th, 2024

A Structured Approach to Benefit-Risk Assessment Throughout Product Development in the Pharmaceutical Industry

perspectives

June 6th, 2024

Datacise and Diversity in Patient Enrollment: Combining Geospatial and Demographic Data to Aid Site Selection

perspectives

May 29th, 2024

Confined Deferrals in Clinical Trial Applications: Anticipating the Revised EU CTR Transparency Rules

perspectives

May 21st, 2024

Psychedelics and Regulatory Considerations Part II: A Shift in Lexicon and Implications of “Nonmedical Use” On Labelling

perspectives

May 10th, 2024

Psychedelics in Drug Development and Regulatory Considerations Part I: Benefit-Risk

perspectives

April 29th, 2024

Validation of Clinical Dashboards for Decision Making